Morning Briefing
Summaries of health policy coverage from major news organizations
The Scientist Examines How Nonprofit, For-Profit Pharma Groups Are Working Together To Make Drugs More Affordable For Developing Countries
"With philanthropists funneling billions of dollars into biomedical research and traditional drug discovery efforts producing fewer and fewer therapies, the line between for-profit and nonprofit life science companies is beginning to blur as both sides of the divide look for new options," The Scientist magazine writes in an article that examines the rise in collaborations between nonprofit pharmaceutical companies and for-profit groups. "More and more for-profit enterprises are experimenting with nonprofit models, while nonprofit organizations look to incorporate for-profit business practices to stay afloat."
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
